Stifel lowered the firm’s price target on RXO Inc. (RXO) to $15 from $16 and keeps a Hold rating on the shares. As the firm awaits the Q4 print, supply side dynamics look better than at any point since COVID, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO: